Pharmacy Daily | Cannabis scheduling

INPUT is sought by the Therapeutic Goods Administration (TGA) relating to the proposed amendments to the Poisons Standard - ACMS and ACCS meeting in March this year. A number of products are being proposed for scheduling changes including cannabis and cannabinoids, which would be listed as new schedule 8 entries, downscheduling them from their current inclusion in schedule 9. The TGA has created a separate Q&A page to clarify the proposal and its implications. The TGA says making cannabinoids S8 “still allows very strict controls on access to the substances,” with the move following last year’s announcement by health minister Sussan Ley that she would seek parliamentary approval of amendments to the Narcotic Drugs Act 1967 to establish a national scheme to allow the cultivation of cannabis for medicinal purposes (PD 17 Oct). Other changes proposed include the up-scheduling of the schedule 4 entry for benzodiazepine derivatives to schedule 9, except where separately specified.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 16